Volver a Agenda
Sponsored Session: Case Study hosted by IQVIA: Reduce Time, Cost, and Risk, from Drug Discovery Through Post-Registration
Session Chair(s)
Sponsored Sessions
United States
Reduce Time, Cost, and Risk, from Drug Discovery Through Post-Registration
Life sciences organizations are often strained by the demand of regulatory complexity and maintaining compliance in different geographies. In addition, keeping up with the ever-changing regulatory landscape can be time-consuming and costly in the drug development continuum.
Learn how IQVIA’s Regulatory Affairs and Drug Development Solutions (RADDS) provides data-driven strategic drug development and technology-enabled services to drive efficiency in regulatory affairs, operations, submissions, and regulatory intelligence along the entire lifecycle of the product.
Featured Topics:- Regulatory strategy across the entire drug development continuum
- Maximize early strategic advantages to enable operational efficiency
- Enhance regulatory affairs from pre-registration to post-registration
- Use AI/ML and regulatory intelligence tools to lower administrative burdens
Speaker(s)
Instructor
Michelle Gyzen
IQVIA, United States
Senior Director, Regulatory Innovation & Technology
Instructor
Michel Francois Denarie, MBA
IQVIA, United States
Senior Principal, Regulatory Affairs and Drug Development Solutions
¿Tiene una cuenta?